Project Details
Description
SPR001-202: A 3-Month Phase 2 Study to Evaluate the Safety and Efficacy of SPR001 in Subjects with Classic Congenital Adrenal Hyperplasia
| Status | Finished |
|---|---|
| Effective start/end date | 1/14/19 → 1/31/24 |
Funding
- SPRUCE BIOSCIENCES, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.